The reinfection threshold promotes variability in tuberculosis epidemiology and vaccine efficacy
- 22 March 2004
- journal article
- Published by The Royal Society in Proceedings Of The Royal Society B-Biological Sciences
- Vol. 271 (1539), 617-623
- https://doi.org/10.1098/rspb.2003.2606
Abstract
Population patterns of infection are determined largely by susceptibility to infection. Infection and vaccination induce an immune response that, typically, reduces susceptibility to subsequent infections. With a general epidemic model, we detect a ‘reinfection threshold’, above which reinfection is the principal type of transmission and, consequently, infection levels are much higher and vaccination fails. The model is further developed to address human tuberculosis (TB) and the impact of vaccination. The bacille Calmette–Guérin (BCG) is the only vaccine in current use against TB, and there is no consensus about its usefulness. Estimates of protection range from 0 to 80%, and this variability is aggravated by an association between low vaccine efficacy and high prevalence of the disease. We propose an explanation based on three postulates: (i) the potential for transmission varies between populations, owing to differences in socio–economic and environmental factors; (ii) exposure to mycobacteria induces an immune response that is partially protective against reinfection; and (iii) this protection is not significantly improved by BCG vaccination. These postulates combine to reproduce the observed trends, and this is attributed to a reinfection threshold intrinsic to the transmission dynamics. Finally, we demonstrate how reinfection thresholds can be manipulated by vaccination programmes, suggesting that they have a potentially powerful role in global control.Keywords
This publication has 37 references indexed in Scilit:
- Infection, reinfection, and vaccination under suboptimal immune protection: epidemiological perspectivesJournal of Theoretical Biology, 2004
- On the determinants of population structure in antigenically diverse pathogensProceedings Of The Royal Society B-Biological Sciences, 2002
- An Analysis of Some Hypotheses Related to the Chingelput Bacille Calmette-Guérin TrialClinical Infectious Diseases, 2000
- Exogenous Reinfection as a Cause of Recurrent Tuberculosis after Curative TreatmentNew England Journal of Medicine, 1999
- Prospects for worldwide tuberculosis control under the WHO DOTS strategyThe Lancet, 1998
- Cross immunity and vaccination against multiple microparasite strainsMathematical Medicine and Biology: A Journal of the IMA, 1998
- Control Strategies for Tuberculosis Epidemics: New Models for Old ProblemsScience, 1996
- The development of clinical tuberculosis following infection with tubercle bacilliTubercle, 1982
- Pathogenesis of Tuberculosis and Effectiveness of BCG VaccinationTubercle, 1982
- A contribution to the mathematical theory of epidemicsProceedings of the Royal Society of London. Series A, Containing Papers of a Mathematical and Physical Character, 1927